Patents by Inventor Eva Hernando-Monge

Eva Hernando-Monge has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • TREATMENT OF MELANOMA BRAIN METASTASIS BY INHIBITION OF AMYLOID PRECURSOR PROTEIN CLEAVAGE
    Publication number: 20210309726
    Abstract: Provided are methods for treating cancer brain metastases by inhibiting amyloid precursor protein (APP) cleavage or the activity of the APP cleavage products, or both in the brain. The process may be inhibited by an inhibitor of ?-, ?-, or ?-secretase, or by an antibody specific for one or more of sAPP?, sAPP?, CTF83, CTF99, p3, A?, and AICD.
    Type: Application
    Filed: May 21, 2019
    Publication date: October 7, 2021
    Inventors: Kevin KLEFFMAN, Eva HERNANDO-MONGE, Robert SCHNEIDER
  • METHOD FOR PREDICTING DEVELOPMENT OF MELANOMA BRAIN METASTASIS
    Publication number: 20160298198
    Abstract: The invention relates to miRNA-based methods for prognosis of melanoma brain metastasis and related methods and kits. In one embodiment, the invention provides a method for predicting the likelihood of developing melanoma brain metastasis (B-Met) in a subject diagnosed with primary melanoma, said method comprising determining the levels of miR-150-5p, miR-15b-5p, miR-16-5p, and miR-374b-3p in a primary melanoma sample collected from the subject.
    Type: Application
    Filed: November 13, 2014
    Publication date: October 13, 2016
    Applicant: New York University
    Inventors: Eva Hernando-Monge, Douglas Hanniford, Hua Zhong, Iman Osman
  • METHOD FOR PREDICTING RECURRENCE OF MELANOMA USING miRNA ALTERATIONS
    Publication number: 20150126621
    Abstract: Described herein are miRNA-based methods for prognosis of recurrence of melanoma and related methods and kits. The present invention addresses these and other needs by providing a method for predicting the likelihood of recurrence of melanoma (including distal metastasis and locoregional recurrence) in a subject diagnosed with melanoma. In a separate aspect, the invention provides a method for treatment of a melanoma recurrence (including distal metastasis and locoregional recurrence) in a subject in need thereof.
    Type: Application
    Filed: May 15, 2013
    Publication date: May 7, 2015
    Applicant: New York University
    Inventors: Douglas Hanniford, Eva Hernando-Monge, Iman Osman, Shulian Shang, Yongzhao Shao